Join Visiopharm on September 10th, 2013at 10 AM EST / 4 PM CET for our webinar “The Use of Image Analysis in Biomarker Qualification.” The webinar will be presented by Dr. Stephen Hewitt a Clinical Investigator within the Laboratory of Pathology, chief of the Tissue Array Research Program, and chief of the Applied Molecular Pathology Laboratory at the National Cancer Institute.
Register today at: https://www1.gotomeeting.com/register/417199280
Visiopharm offers over 25 ready-to-run Application Protocol Packages (APPs) for Cancer Research and biomarker quantification. APPs are image analysis protocols designed both for common and more specialized needs. Visit the Visiopharm website to learn more about these cost effective, easy-to-use APPs and our TissuemorphDP software to execute or design your own APP.
The application of immunohistochemistry to tissue has evolved substantially over the last two decades. Once a tool to understand cell type (lineage) and categorize disease in a clinical setting, it is not routinely applied to proteins that are integral to signaling cascades. With this shift in application, the interpretation of immunohistochemistry has moved from presence or absence in cells of interest to quantification. With quantification, comes integration of the information with other markers, as well as clinico-pathologic information. The application of image analysis, and the quantitative data that results substantially refines disease models. This webinar will address image analysis as a part of a “total test” approach from specimen to interpretation, and the capacity to ask more complex questions in biomedical research.
About our Speaker
Stephen M. Hewitt, M.D., Ph.D., is appointed as a Clinical Investigator within the Laboratory of Pathology, Center for Cancer Research, National Cancer Institute at the National Institutes of Health, in Bethesda Maryland. He has served as chief of the Tissue Array Research Program since its inception in 2000, and as chief of the Applied Molecular Pathology Laboratory since its creation in 2008.
Dr. Hewitt’s research interests are in the development of tissue-based biomarkers for cancer diagnosis, prognosis and prediction of response to therapy. Specific areas of concentration include tissue microarrays, biobanking of pathology specimens, tissue proteomics, whole slide imaging /image analysis, and cancers of the aero-digestive and urogenitial tracts.
Stephen received his bachelor’s degree in philosophy from the Johns Hopkins University in 1988, and his Ph.D. in genetics from the University of Texas, Graduate School of Biomedical Sciences in 1995, having completed his thesis in the laboratory of Grady Saunders at the University of Texas M.D. Anderson Cancer Center. He completed his M.D. in 1996 at the University of Texas Medical School at Houston, and his residency in Anatomic Pathology within the Laboratory of Pathology at the National Cancer Institute. He is a board certified Anatomic Pathologist and Fellow of the College of American Pathologists. Dr. Hewitt is a member of the Clinical Laboratory Standards Institute Immunology & Ligand Assay Consensus Committee, having served as co-chair of the Subcommittee on Immunohistochemical Assays. He is a councilor of the Histochemical Society, Program Committee Chair-elect for the Association for Pathology Informatics and a consultant to the Hematology and Pathology Devices Panel, Center for Devices and Radiological Health, Food and Drug Administration. Dr Hewitt has co-authored more than 200 articles and servers on the editorial board of four peer-reviewed journals.